Table 2 Prevalence of HPV6/11/16/18 infection patterns in different age groups and in every year.

From: Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China

 

HPV6 (n,%)

HPV11 (n,%)

Single

Double

Triple

Quad+

Total

Single

Double

Triple

Quad+

Total

Age (years)

 < 20(n = 797)

15 (1.88)

18 (2.26)

14 (1.76)

19 (2.38)

66 (8.28)

16 (2.01)

7 (0.88)

5 (0.63)

8 (1.0)

36 (4.52)

20–29 (n = 65,432)

387 (0.59)

227 (0.35)

126 (0.19)

83 (0.13)

823 (1.26)

261 (0.40)

128 (0.20)

51 (0.08)

27 (0.04)

467 (0.71)

30–39(n = 69,485)

264 (0.38)

146 (0.21)

50 (0.07)

27 (0.04)

487 (0.70)

197 (0.28)

91 (0.13)

22 (0.03)

12 (0.02)

322 (0.46)

40–49(n = 29,963)

99 (0.33)

52 (0.17)

22 (0.07)

6 (0.02)

179 (0.60)

57 (0.19)

27 (0.09)

8 (0.03)

5 (0.02)

97 (0.32)

50–59(n = 12,002)

48 (0.40)

32 (0.27)

22 (0.18)

10 (0.08)

112 (0.93)

37 (0.31)

19 (0.16)

4 (0.03)

4 (0.03)

64 (0.53)

 ≥ 60(= 2597)

12 (0.46)

7 (0.27)

8 (0.31)

5 (0.19)

32 (1.24)

17 (0.65)

8 (0.31)

3 (0.12)

5 (0.19)

33 (1.28)

χ2

33.881

27.661

14.236

40.502

104.159

16.055

7.628

12.651

3.041

35.946

P

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.006

 < 0.001

0.081

 < 0.001

Year

2015

69 (38.98)

54 (30.51)

29 (16.38)

25 (14.12)

177

65 (52.85)

34 (27.64)

13 (10.57)

11 (8.94)

123

2016

117 (47.56)

64 (26.02)

38 (15.45)

27 (10.98)

246

63 (57.80)

30 (27.52)

7 (6.42)

9 (8.26)

109

2017

141 (47.80)

90 (30.51)

44 (14.92)

20 (6.78)

295

94 (59.87)

42 (26.75)

11 (7.01)

10 (6.37)

157

2018

160 (47.62)

107 (31.85)

45 (13.39)

24 (7.14)

336

118 (53.88)

65 (29.68)

25 (11.42)

11 (5.02)

219

2019

141 (49.13)

81 (28.22)

40 (13.94)

25 (8.71)

287

128 (59.53)

55 (25.58)

22 (10.23)

10 (4.65)

215

2020

99 (52.66)

42 (22.34)

26 (13.83)

21 (11.17)

188

52 (49.52)

38 (36.19)

9 (8.57)

6 (5.71)

105

2021

98 (57.65)

44 (25.88)

20 (11.76)

8 (4.71)

170

65 (71.43)

16 (17.58)

6 (6.59)

4 (4.40)

91

 

HPV16 (n,%)

HPV18 (n,%)

Single

Double

Triple

Quad+

Total

Single

Double

Triple

Quad+

Total

Age (years)

 <20(n = 797)

14 (1.76)

15 (1.88)

14 (1.76)

17 (2.13)

60 (7.53)

10 (1.25)

13 (1.63)

6 (0.75)

10 (1.25)

39 (4.89)

20–29 (n = 65,432)

1207 (1.84)

633 (0.97)

256 (0.39)

141 (0.22)

2237 (3.42)

475 (0.73)

257 (0.39)

116 (0.18)

86 (0.13)

934 (1.43)

30–39(n = 69,485)

1351 (1.94)

469 (0.67)

142 (0.20)

53 (0.08)

2015 (2.90)

488 (0.70)

194 (0.28)

58 (0.08)

42 (0.06)

782 (1.13)

40–49(n = 29,963)

577 (1.93)

207 (0.69)

51 (0.17)

18 (0.06)

853 (2.85)

206 (0.69))

79 (0.26)

28 (0.09)

12 (0.04)

325 (1.08)

50–59(n = 12,002)

285 (2.37)

99 (0.82)

31 (0.26)

30 (0.25)

445 (3.71)

98 (0.82)

45 (0.37)

19 (0.16)

17 (0.14)

179 (1.49)

 ≥ 60(= 2597)

88 (3.39)

53 (2.04)

30 (1.16)

20 (0.77)

191 (7.42)

22 (0.85)

16 (0.62)

3 (0.12)

10 (0.39)

51 (1.98)

χ2

23.794

2.264

8.767

3.171

3.123

0.099

4.123

9.898

3.701

5.48

P

 < 0.001

0.132

0.003

0.075

0.077

0.753

0.042

0.002

0.054

0.019

Year

2015

329 (54.29)

181 (29.87)

54 (8.91)

42 (6.93)

606

152 (57.58)

61 (23.11)

26 (9.85)

25 (9.47)

264

2016

423 (57.79)

213 (29.10)

55 (7.51)

41 (5.60)

732

161 (56.69)

68 (23.94)

25 (8.80)

30 (10.56)

284

2017

536 (54.64)

219 (22.32)

91 (9.28)

44 (4.49)

981

241 (57.24)

101 (23.99)

49 (11.64)

30 (7.13)

421

2018

665 (60.29)

280 (25.39)

116 (10.52)

42 (3.81)

1103

232 (59.18)

104 (26.53)

40 (10.20)

16 (4.08)

392

2019

699 (61.21)

285 (24.96)

106 (9.28)

52 (4.55)

1142

203 (51.52)

117 (29.70)

40 (10.15)

34 (8.63)

394

2020

522 (64.13)

174 (21.38)

69 (8.48)

49 (6.02)

814

146 (50.52)

88 (30.45)

27 (9.34)

28 (9.69)

289

2021

348 (67.70)

124 (24.12)

33 (6.42)

9 (1.75)

514

164 (61.65)

65 (24.44)

23 (8.65)

14 (5.26)

266